LONZA WALKERSVILLE, INC. — FDA Facility Profile

FEI 1114298

LONZA WALKERSVILLE, INC. is an FDA-registered facility (FEI 1114298) located in WALKERSVILLE, MD, US. RegDataLab tracks 11 FDA inspections and 1 compliance action at this facility.

Reviewing LONZA WALKERSVILLE, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check LONZA WALKERSVILLE, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Mar 24, 2026: No Action Indicated (NAI)
Inspections on record
11 (1 OAI, 6 VAI, 4 NAI)
Last OAI inspection
Feb 6, 2017
Warning letters
1 listed by FDA for this FEI, latest Apr 21, 2017

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 11 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 24, 2026No Action Indicated (NAI)No citations listed
Nov 5, 2021Voluntary Action Indicated (VAI)Lack of or inadequate complaint procedures (21 CFR 820.198(a))
Contamination control, Lack of or inadequate procedures (21 CFR 820.70(e))
Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
and 2 more
Jul 26, 2018Voluntary Action Indicated (VAI)No citations listed
Jul 3, 2018No Action Indicated (NAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a))
Process control procedures, Lack of or inadequate procedures (21 CFR 820.70(a))
Purchasing controls, Lack of or inadequate procedures (21 CFR 820.50)
Feb 6, 2017Official Action Indicated (OAI)Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Lack of or inadequate procedures (21 CFR 820.100(a))
Lack of or inadequate procedures for handling (21 CFR 820.140)
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
and 6 more
Jun 9, 2016Voluntary Action Indicated (VAI)No citations listed
Aug 13, 2013Voluntary Action Indicated (VAI)No citations listed
Dec 2, 2011Voluntary Action Indicated (VAI)Lack/Inad procedure-Monitoring/Control of Validated Proces (21 CFR 820.75(b))
Storage procedures to avoid release of unsuitable product (21 CFR 820.150(a))
Identification of actions needed (21 CFR 820.100(a)(3))
Lack of procedures, or not maintained (21 CFR 820.40)
and 4 more
Aug 23, 2011No Action Indicated (NAI)No citations listed
Dec 17, 2009No Action Indicated (NAI)No citations listed

Facility details

Company
Lonza Walkersville, Inc.
Location
WALKERSVILLE, MD (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.